Home Healthcare Medical Devices Fluoroscopy Devices Market

Fluoroscopy Devices Market Size, Share & Trends Analysis Report By Device Type (Fixed Fluoroscopes, Mobile Fluoroscopes, Full-size Fluoroscopes, Mini Fluoroscopes), By Application (Orthopedic, Cardiovascular, Pain Management & Trauma, Neurology, Gastrointestinal, Urology, General Surgery, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Fluoroscopy Devices Market Size

The global fluoroscopy devices market size was valued at USD 5.53 billion in 2025 and is projected to grow from USD 5.80 billion in 2026 to USD 8.51 billion by 2034, registering a CAGR of 4.91% during the forecast period from 2026 to 2034. North America dominated the fluoroscopy devices market with a market share of 38.5% in 2025.

Fluoroscopy is an improved X-ray technique that creates moving images of an item on a screen or monitor that resembles a television. It is mainly employed for gastrointestinal tract imaging to identify clinical problems such as tumors, ulcers, inflammation, blockages, etc. The key factors propelling the fluoroscopy devices market include the increasing applications in clinical diagnostics, rising demand for minimally technological advancements, invasive surgeries, and its application in multiple disease conditions. The prevalence of several chronic diseases has significantly increased over the past decade. The threat of these diseases to public health has increased dramatically, resulting in the growing adoption of new diagnostic techniques, thus contributing to market growth.

Fluoroscopy Devices Market Size

Download a Free Sample To learn more about this report.

Type Insights

The Fixed Fluoroscopes segment accounts for the largest market share and is estimated to grow at a CAGR of 5.9% during the forecast period. Fixed fluoroscopes, unlike mobile fluoroscopes, include massive remote generators that can deliver greater power for better tissue penetration and imaging quality. The market is seeing the introduction of many significant players' sophisticated fixed fluoroscopic products. For instance, in 2021, GE Healthcare unveiled the Definium Tempo, a brand-new fixed, overhead tube suspension (OTS) digital X-ray system that aims to serve as a personal assistant to radiologists and technologists by leveraging automation to ease workload burdens and support radiology departments in providing the best patient care possible. Therefore, factors such as innovation in the products, and automation, among other constituents, are expected to drive this segment growth.

Fluoroscopy Devices Market Size By Segments

Request Customizationto receive a tailored report.

Application Insights

The global market is segmented into Orthopedic, Cardiovascular, Pain Management & Trauma, Neurology, Gastrointestinal, Urology, General Surgery, and Others.

The Cardiovascular segment accounts for the largest market share and is estimated to grow at a CAGR of 5.6% during the forecast period. Rising product launches related to fluoroscopy of cardiovascular conditions are expected to drive market growth further. For instance, Siemens Healthineers launched the Luminos Impulse fluoroscopy system, including a seamless imaging chain, comprehensive dose optimization, cybersecurity features, and detector-sharing capabilities for radiography.

Fluoroscopic guided percutaneous coronary intervention is a commonly used method to treat coronary artery disease, according to a study published in 2021 on Fluoroscopic Percutaneous Coronary Interventions, Assessment, Protocols, and Interpretation. Ionizing radiation was used to perform almost all percutaneous coronary interventions under fluoroscopic supervision. During the percutaneous coronary intervention, it is crucial to take the proper fluoroscopic images based on the vessel anatomy to prevent missing the affected section. Therefore, the rising adoption of fluoroscopy in cardiovascular diseases is expected to propel segment growth.

The Orthopedic segment is the second largest. According to the American Academy of Orthopedic Surgeons (AAOS) 2019 report, overall, orthopedists perform an average of 30 procedures per month, and full-time practicing orthopedic surgeons undertake an average of 32 orthopedic procedures every month, which is more than one surgery per day (and this assumes surgeons are on seven days per week). The rising adoption of orthopedic surgeries is expected to fuel the growth of this segment.

Fluoroscopy Devices Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

North America accounts for the largest market share and is estimated to grow at a CAGR of 5.7% during the forecast period. The United States has the presence of several medical technology companies and strong market players engaged in product launches, thereby expanding the growing scope of the market. For instance, in November 2020, FUJIFILM Medical Systems USA Inc., a leading provider of diagnostic imaging and medical informatics solutions, introduced two new systems, namely the Persona C Surgical C-Arm and Persona RF PREMIUM System. These systems may provide digital X-ray imaging studies and fluoroscopy exams, allowing physicians to enhance workflow and assess patients' conditions. The strategic move expanded the company's medical imaging portfolio.

Additionally, ControlRad Inc., a privately held medical technology company that aims to reduce unnecessary radiation exposure during fluoroscopically guided procedures significantly has started its commercial launch after receiving approval from the US Food and Drug Administration (USFDA) for its ControlRad Trace product. The controlled Trace is the only radiation reduction technique now incorporated into mobile C-arms for fluoroscopic imaging. Such advancements are anticipated to stimulate the creation of additional cutting-edge fluoroscopes, supporting market expansion.

North America Fluoroscopy Devices Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Europe: Fastest Growing Region

Europe is the second-largest region and is estimated to reach an expected value of USD 1,680 million by 2030, registering a CAGR of 6%. The factors contributing to the growth of the fluoroscopy market in Germany are the rising incidences of chronic disorders, growing preference for minimally invasive surgery, increasing geriatric population, and implementation of strategic initiatives by some market players. For instance, the Federal Statistical Office (Destatis) forecasts that between 2020 and 2035, the number of persons aged 67 or older will increase by 22%, from 16 million to an anticipated 20 million.

As the older population is prone to chronic disorders, the rise in the geriatric population will enhance the demand for fluoroscopes in Germany. Additionally, the Statistisches Bundesamt (Destatis) article titled "Number of deaths fell by 1.6% in 2019" reported that a total of 939,520 people died in Germany in 2019, and the most common cause of death was cardiovascular disease. It also accounted for 3,31,211 (35.3% of all deaths) people who died from cardiovascular disease in 2019, of which 1,52,615 were men and 1,78,596 women in Germany. These statistics reflect the increasing usage of fluoroscopes in the country.

Asia-Pacific is the third-largest region. The major factors fueling the growth of the fluoroscopy market in China are the increasing prevalence of cardiovascular disorders, the rising geriatric population, increasing research and development of fluoroscopy, and improving healthcare infrastructure. In addition, as per the National Institute of Ageing, adults 65 years and older are more likely to suffer from cardiovascular diseases (CVDs) as aging can cause changes in heart and blood vessels that increase the risk of developing CVDs in the older population.

As per the 2021 estimates by the World Health Organization (WHO), China has one of the fastest-growing aging populations. The population above 60 years old in China is projected to reach 28% by the year 2040. This reflects that with an increase in the geriatric population, the prevalence of CVDs will increase in China. A significant population will undergo fluoroscopy procedures related to the heart septum, appendage, and valves. Moreover, the increasing preference for minimally invasive surgery significantly contributes to China's high demand for fluoroscopy devices.

List of Key and Emerging Players in Fluoroscopy Devices Market

Canon Medical Systems Corporation
Carestream Health
General Electric Company (GE Healthcare)
FUJIFILM Holdings Corporation
Hologic Inc.
Koninklijke Philips NV
ATON GmbH (Ziehm Imaging Inc. and OrthoScan Inc.)
Shimadzu Medical
Siemens Healthcare GmbH.

Key Industry Developments

November 2025
Canon Medical Systems received FDA 510(k) clearance for the Alphenix / Evolve Edition with αEvolve Imaging. The system incorporates AI-based denoising to improve fluoroscopic image quality while reducing radiation dose. It enhances the company's interventional imaging solutions.
October 2025
Philips announced the installation of its 5,000th Zenition mobile C-arm system worldwide. The milestone highlights the growing adoption of its fluoroscopy devices for image-guided surgical procedures. It strengthens the company's position in the global fluoroscopy market.
July 2025
Siemens Healthineers received U.S. FDA clearance for the Luminos Q.namix R and Luminos Q.namix T radiography/fluoroscopy platforms. The systems feature AI-powered workflows and support both remote and tableside examinations. They expand the company's fluoroscopy imaging portfolio.
March 2025
Canon Medical Systems commercially launched the Adora DRFi hybrid radiography and fluoroscopy system in the U.S. following FDA 510(k) clearance. The platform combines digital radiography and fluoroscopy in a single system to improve workflow efficiency. It strengthens the company's diagnostic imaging portfolio.

Report Scope

Segmentation

By Device Type 4
  • Fixed Fluoroscopes
  • Mobile Fluoroscopes
  • Full-size Fluoroscopes
  • Mini Fluoroscopes
By Application 8
  • Orthopedic
  • Cardiovascular
  • Pain Management & Trauma
  • Neurology
  • Gastrointestinal
  • Urology
  • General Surgery
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Canon Medical Systems Corporation · Carestream Health · General Electric Company (GE Healthcare) · FUJIFILM Holdings Corporation · Hologic Inc.
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The fluoroscopy devices market size is valued at USD 5.80 Billion in 2026 and is projected to reach USD 8.51 Billion by 2034, at a CAGR of 4.91% during the forecast period 2026-2034.

North America dominated the market with a share of 38.5% in 2025.

The leading players in this market are Canon Medical Systems Corporation, Carestream Health, General Electric Company, FUJIFILM Holdings Corporation, Hologic Inc..

The fluoroscopy devices market is projected to grow at a CAGR of 4.91% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: